Danni Yu

Danni Yu is an Executive Director in Biostatistics at Nektar Therapeutics with extensive experience in clinical trials, study design, analysis, and result interpretation. Prior to this role, Danni held positions at Eli Lilly and Company and the National Institutes of Health, where Danni worked on identifying biomarkers for various therapies. Danni's educational background includes a Ph.D in Statistics from Purdue University.